Straits Times Index
3,300.00 -4.00 (-0.12%) S&P 500
5,487.03 +13.80 (+0.25%) Dow
38,834.86 +56.76 (+0.15%) Nasdaq
17,862.23 +5.21 (+0.03%) Bitcoin USD
65,993.48 +953.75 (+1.47%) CMC Crypto 200
1,375.41 -7.25 (-0.53%)
VKTX Nov 2024 65.000 call
| Previous close | 8.00 |
| Open | 8.65 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 65.00 |
| Expiry date | 2024-11-15 |
| Day's range | 8.00 - 8.65 |
| Contract range | N/A |
| Volume | |
| Open interest | 50 |
Insider MonkeyHere’s Why Viking Therapeutics (VKTX) Stock Skyrocketed in Q1
Wasatch Global Investors, an asset management company, released its “Wasatch Micro Cap Growth—U.S. Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. During the first quarter, the micro-cap equities performed well. The strategy had a double-digit gain in the quarter, outperforming the Russell Microcap Growth Index benchmark, which rose 6.60%. […]
ZacksViking Therapeutics, Inc. (VKTX) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $52.10, denoting a -0.69% change from the preceding trading day.
ZacksWall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?
According to the average brokerage recommendation (ABR), one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
